MRE-269, 99.14%
cas: 475085-57-5 — see every product listed under this CAS number, including other names
MRE-269, 99.14% (CAS 475085-57-5) is a chemical reagent available from Chemat. Available pack sizes: 10 mg, 5 mg, 50 mg, 100 mg, 10mM/1mL. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-79593-10 mg |
| cas | 475085-57-5 |
| size | 10 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 10 mg | 649.42 Pln | |
| MedChemExpress | 5 mg | 407.93 Pln | |
| MedChemExpress | 50 mg | 1318.15 Pln | |
| MedChemExpress | 100 mg | 2279.46 Pln | |
| MedChemExpress | 10mM/1mL | 435.79 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.14% |
ACT-333679 is a member of the class of pyrazines that is {4-[(propan-2-yl)(pyrazin-2-yl)amino]butoxy}acetic acid carrying two additional phenyl substituents at positions 5 and 6 on the pyrazine ring. The active metabolite of selexipag, an orphan drug used for the treatment of pulmonary arterial hypertension. It has a role as a vasodilator agent, a drug metabolite, a platelet aggregation inhibitor, an orphan drug and a prostacyclin receptor agonist. It is a monocarboxylic acid, an ether, an aromatic amine, a sulfonamide, a member of pyrazines and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C25H29N3O3 |
|---|---|
| Molecular weight | 419.5 g/mol |
| IUPAC name | 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]acetic acid |
| InChIKey | OJQMKCBWYCWFPU-UHFFFAOYSA-N |
| SMILES | CC(C)N(CCCCOCC(=O)O)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3 |
Computed by PubChem (NCBI)
Synonyms:
{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid, 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]acetic acid, (4-((5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy)acetic acid, 2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)acetic acid, 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid, Laselipag, (4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid, Selexipag active metabolite, 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]acetic acid, 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetic acid